GATC Health’s AI Capabilities Integrated into Bioneex
SAN FRANCISCO and IRVINE, Calif., Sept. 16, 2025 (GLOBE NEWSWIRE) — Bioneex.com, the world’s leading AI-powered marketplace platform for novel therapeutic assets, and GATC Health Corp, a leader in AI-driven drug discovery and risk analytics, are pleased to announce the integration of GATC Health’s predictive analysis capabilities into the Bioneex platform. This integration delivers advanced AI-driven predictions of drug candidate performance, providing greater confidence in asset validation for the global biotech and investment community.
“This collaboration elevates Bioneex’s AI-powered marketplace platform by providing our users with the most advanced, validated drug candidate analytics available. GATC’s data-driven predictive assessment empowers drug development companies, as well as strategic biopharma partners and venture capital investors, to make smarter, data-driven decisions,” said Bioneex Founder and CEO Dr. Smbat Rafayelyan.
Read the release here.
About GATC
GATC Health is a tech-bio company revolutionizing drug discovery and development by simulating complex human biology to predict how drugs will perform in the body, achieving 91% specificity and 86% sensitivity. Trusted by the world’s largest insurance marketplace, biopharma, researchers, and investment partners, GATC Health’s risk prediction product, the Derisq™ AI report, accurately assesses and predicts drug candidate safety, efficacy, and non-obvious side effects prior to the commitment of development capital. GATC Health’s AI platform is also generative, creating novel intellectual property, extending pipelines, and optimizing assets. By uniting advanced AI, multiomics, and predictive modeling, GATC Health accelerates breakthroughs and reduces costly late-stage failures to bring safer, more effective therapies to patients worldwide. For more information, visit www.gatchealth.com.
Contact Us
Similar News
GATC Health’s President Dr. Rahul Gupta to Highlight Opioid Use Disorder Drug Candidate at Recovery Day at the Capitol in West Virginia
Irvine, CA – April 10, 2025 – GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug discov…
Read more
Mark Cuban Is All-In on AI
It’s hard to imagine a public figure who is more bullish on artificial intelligence than Mark Cuban. As a tech entrepreneur and self-made b…
Read more
GATC Health Paper Quantifies AI-Driven Capital Efficiencies and Advances Human-Centered Drug Discovery
Irvine, Calif. – May 22, 2025 – GATC Health Corp, a leading tech-bio company leveraging artificial intelligence (AI) to transform drug disc…
Read more